Stem cell transplantation for metastatic breast cancer: Analysis of tumor contamination

Medical Oncology

Volumn 16, Issue 4, 1999, Pages 279-288

  Stadtmauer, E A ^a   Tsai, D E ^a   Sickles, C J ^a   Mick, R ^a   Luger, S M ^a   Porter, D L ^a   Mangan, P A ^a   Schuchter, L M ^a   Schuster, S J ^a   Loh, E Y ^a   Magee, D A ^a   Sachs, R A ^a   Wall, M E ^a   Moore, J ^a   Buzby, G P ^a   Zaleta, E ^a   Kamoun, M ^a   Silberstein, L E ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone marrow transplantation; Metastatic breast cancer; Tumor contamination

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TOXICITY; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033392899     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02785874     Document Type: Article

References (27)